• Bulletin of the Korean Chemical Society
• /
• 제34권8호
• /
• pp.2297-2304
• /
• 2013

A series of novel benzimidazole derivatives bearing a heterocyclic ring as oxadiazole (21-32), thiadiazole (33-34), triazole (35-36) were synthesized and evaluated for their activities against Coxsackie virus B3 and B6 in Vero cells. Compounds 21-26, 31-36 with moieties of 2'-pyridyl, 3'-pyridyl and 4'-pyridyl at the 2-position and oxadiazoles, thiadiazole, or triazole substituent at the 4- or 5-position generally displayed activities against CVB3 and CVB6. Especially compound 24 ($IC_{50}=1.08{\mu}g/mL$, SI = 61.7 against CVB3) was the promising candidate as lead compound for anti-enteroviral drug. It was observed in the incorporation of heterocyclic rings in benzimidazole at the 5-position could enhance their biological activities.

• Journal of Ginseng Research
• /
• 제38권3호
• /
• pp.173-179
• /
• 2014

Background: Ginsenosides are the major components responsible for the biochemical and pharmacological actions of ginseng, and have been shown to have various biological activities. In this study, we investigated the antiviral activities of seven ginsenosides [protopanaxatriol (PT) type: Re, Rf, and Rg2; protopanaxadiol (PD) type: Rb1, Rb2, Rc, and Rd)] against coxsackievirus B3 (CVB3), enterovirus 71 (EV71), and human rhinovirus 3 (HRV3). Methods: Assays of antiviral activity and cytotoxicity were evaluated by the sulforhodamine B method using the cytopathic effect (CPE) reduction assay. Results: The antiviral assays demonstrated that, of the seven ginsenosides, the PT-type ginsenosides (Re, Rf, and Rg2) possess significant antiviral activities against CVB3 and HRV3 at a concentration of $100{\mu}g/mL$. Among the PT-type ginsenosides, only ginsenoside Rg2 showed significant anti-EV71 activity with no cytotoxicity to cells at $100{\mu}g/mL$. The PD-type ginsenosides (Rb1, Rb2, Rc, and Rd), by contrast, did not show any significant antiviral activity against CVB3, EV71, and HRV3, and exhibited cytotoxic effects to virus-infected cells. Notably, the antiviral efficacies of PT-type ginsenosides were comparable to those of ribavirin, a commonly used antiviral drug. Conclusion: Collectively, our findings suggest that the ginsenosides Re, Rf, and Rg2 have the potential to be effective in the treatment of CVB3, EV71, and HRV3 infection.

• Biomolecules & Therapeutics
• /
• 제25권3호
• /
• pp.279-287
• /
• 2017

The chemical property of cinnamaldehyde is unstable in vivo, although early experiments have shown its obvious therapeutic effects on viral myocarditis (VMC). To overcome this problem, we used cinnamaldehyde as a leading compound to synthesize derivatives. Five derivatives of cinnamaldehyde were synthesized: 4-methylcinnamaldehyde (1), 4-chlorocinnamaldehyde (2), 4-methoxycinnamaldehyde (3), ${\alpha}$-bromo-4-methylcinnamaldehyde (4), and ${\alpha}$-bromo-4-chlorocinnamaldehyde (5). Neonatal rat cardiomyocytes and HeLa cells infected by coxsackievirus B3 (CVB3) were used to evaluate their antiviral and cytotoxic effects. In vivo BALB/c mice were infected with CVB3 for establishing VMC models. Among the derivatives, compound 4 and 5 inhibited the CVB3 in HeLa cells with the half-maximal inhibitory concentrations values of $11.38{\pm}2.22{\mu}M$ and $2.12{\pm}0.37{\mu}M$, respectively. The 50% toxic concentrations of compound 4 and 5-treated cells were 39-fold and 87-fold higher than in the cinnamaldehyde group. Compound 4 and 5 effectively reduced the viral titers and cardiac pathological changes in a dose-dependent manner. In addition, compound 4 and 5 significantly inhibited the secretion, mRNA and protein expressions of inflammatory cytokines TNF-${\alpha}$, IL-$1{\beta}$ and IL-6 in CVB3-infected cardiomyocytes, indicating that brominated cinnamaldehyde not only improved the anti-vital activities for VMC, but also had potent anti-inflammatory effects in cardiomyocytes induced by CVB3.

• 한국미생물·생명공학회지
• /
• 제37권1호
• /
• pp.33-41
• /
• 2009

알래스카산 낙엽진흙버섯[Porodaedalea pini (Brot.) Murrill] (syn. Phellinus pini)의 자실체 조분쇄물로부터 $100^{\circ}C$에서 4시간 추출하여 건량 수율 20.5%의 건조 분말 열수추출물을 제조하여, HeLa 세포에서 CVB3에 대한 항바이러스 활성을 조사한 결과 plaque 형성을 현저히 억제하였다. 또한, 다른 여러 가지 버섯 추출물에 비해 neuraminidase 활성 저해능이 가장 높았다. 열수 추출물로부터 75% 에탄올 침전으로 건량 수율 28.3%의 저분자 상등액 건조물(ES)과 수율 43.3%의 고분자 침전물 건조물(EP)을 얻었다. 상등액인 ES에서는 항바이러스 활성이 없었지만, 침전물인 EP는 HeLa 세포에서 CVB3바이러스에 대해 농도 의존적으로 plaque 형성을 현저히 억제하였고, $EC_{50}$은 0.45 mg/mL 이었으며, HeLa 세포에 대한 세포독성 $CC_{50}$은 2.25mg/mL 이었다. 또한, EP는 neureminidase 활성을 농도 의존적으로 저해하였으며, 1.7mg/mL에서 약 75%의 효소활성 억제효과를 보였다. 이러한 결과는 낙엽진흙버섯 자실체의 별수추출물로부터 얻어진 에탄을 침전물 EP가 CVB3 뿐만 아니라, influenza virus(Flu)등에 대해서도 광범위하게 항바이러스 활성을 나타낼 가능성을 보여 주었다. EP는 다당류로서 glucose의 함량이 79.8%로 가장 높았고 galactose, xylose, mannose와 fucose를 소량 포함한 수용성 heteroglycan의 일종으로, 소량(12.7%, w/w)의 단백질 또는 작은 펩타이드를 함유한 당단백의 일종일 것으로 사료된다.

• 소프트웨어공모대전
• /
• 통권6호
• /
• pp.298-306
• /
• 2001

• Clinical and Experimental Pediatrics
• /
• 제52권11호
• /
• pp.1234-1240
• /
• 2009

목 적:Enteroviruse (EV)는 영아와 소아에서 가장 흔한 감염의 원인으로 경한 발열성 질환에서 뇌수막염이나 치명적인 심근염까지 다양한 질환을 일으키는 원인이다. 본 연구에서는 국내 중부지역의 EV 유병율에 대해 알아보고자 하였다. 방 법:2005년 4월부터 2006년 10월까지 국내 중부지역에서 발열성 질환이나 뇌수막염이 의심되어 입원한 소아에서 얻은 검체를 모아 RT-PCR을 시행하여 EV를 확인하였고, genotype과 phylogenetic 분석을 위해 direct sequencing을 시행하였다. 결 과:뇌척수액과 대변검체에서 PCR을 시행한 305명의 환아 중 51명(16.7%)에서 EV가 양성을 보였다. 그중 다음의 serotype이 44명에서 확인되었다: Echovirus (ECV) 18 (18 cases, 35.2%), Coxsackievirus (CVB) 5 (13 cases, 25.4%), ECV25 (5 cases, 9.8%), ECV9 (4 cases, 7.8%), ECV5 (3 cases, 5.8%), EV74 (1 case, 1.9%). 2005년 6월과 8월 사이에는 ECV18과 CVB5가 가장 많이 검출되었다. 2006년 7월과 8월 사이에는 ECV25가 가장 많이 검출되었다. 결 론:지속적인 enterovirus 감염의 감시가 필요하며 임상적인 의의가 밝혀져야 할 것이다. 특히 EV74가 처음으로 국내에서 발견되었기에 이를 보고하는 바이다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제28권11호
• /
• pp.1614-1623
• /
• 2015

The objectives of the current experiment were to study the response of the growth performance of early finishing gilts to different net energy (NE) concentrations in diets, and to compare the NE values of diets between calculated NE values and measured NE values using French and Dutch CVB (Centraal Veevoederbureau; Central Bureau for Livestock Feeding) NE systems. In a metabolism trail, the NE concentrations in five diets used for the growth trial were determined based on digestible nutrient concentrations, digestible energy, and metabolizable energy using a replicated $5{\times}5$ Latin square design with 10 barrows (initial body weight [BW], $39.2{\pm}2.2kg$). In a growth trial, a total of 60 early finishing gilts (Landrace${\times}$Yorkshire; initial BW, $47.7{\pm}3.5kg$) were allotted to five dietary treatments of 8.0, 9.0, 10.0, 11.0, and 12.0 MJ NE/kg (calculated, as-is basis) with 12 replicate pens and one pig per pen in a 42-d feeding experiment. The NE and amino acid (AA) concentrations in all diets were calculated based on the values from NRC (2012). Ratios between standardized ileal digestible AA and NE concentrations in all diets were closely maintained. Pigs were allowed ad libitum access to feed and water. Results indicated that calculated NE concentrations in diets (i.e., five dietary treatments) were close to measured NE concentrations using French NE system in diets. The final BW was increased (linear and quadratic, p<0.05) with increasing NE concentrations in diets. Furthermore, average daily gain (ADG) was increased (linear and quadratic, p<0.01) with increasing NE concentrations in diets. There was a quadratic relationship (p<0.01) between average daily feed intake and NE concentrations in diets. Feed efficiency (G:F) was also increased (linear, p<0.01) as NE concentrations in diets were increased. The NE intake per BW gain (kcal NE/kg of BWG) was increased (linear, p<0.01) with increasing NE concentrations in diets that were predicted from both French and Dutch CVB NE systems. Linear regression indicated that predictability of daily NE intake from the BW of pigs was very low for both French ($R^2$, 0.366) and Dutch CVB ($R^2$, 0.374) NE systems. In conclusion, increasing NE concentrations in diets increase BW, ADG, G:F, and NE intake per BW gain of early finishing gilts. The BW of early finishing gilts is not a good sole variable for the prediction of daily NE intake.

• 한국정보기술응용학회:학술대회논문집
• /
• 한국정보기술응용학회 2007년도 추계 국제학술대회
• /
• pp.120-120
• /
• 2007

• 한국식품영양과학회:학술대회논문집
• /
• 한국식품영양과학회 2004년도 Annual Meeting and International Symposium
• /
• pp.116-121
• /
• 2004

To observe the intervening effect of resveratrol on coxsackie virus B3m-induced myocarditis in Balb/c mice and explore the mechanism of intervening effect. Using an animal model of viral myocarditis induced by coxsackie virus B3m (CVB3m), with Ribavirin and Astragalan as comparison, to examine the changes of general condition, mortality, the weights of heart, liver and spleen, serum MDA and NO levels, and cardiac histology in Balb/c mice. By comparison with Ribavirin and Astragalan, it was found that in the mice model of viral myocarditis induced by coxsackie virus B3m resveratrol significantly improved the changes of general condition, mortality, the weights of heart, liver and spleen, serum MDA and NO levels, and cardiac histology. It suggested that resveratrol may have some chemopreventive and chemotherapeutic effects in the treatment of viral myocarditis.

• 한국동물학회:학술대회논문집
• /
• 한국동물학회 1998년도 한국생물과학협회 학술발표대회
• /
• pp.329.2-329
• /
• 1998

No Abstract, See Full Text